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Volume 50, Number 4 Abstracts 969Methods: Records of all patients undergoing treatment for NTOS at
our center were reviewed. Patient demographics and co-morbidities were
recorded. End-points included symptomatic relief, peri-operative adjunctive
procedures, functional outcome, and employment continuity.
Results: From 1988-2008, 26 patients were operated upon for NTOS.
Hallmarks of the diagnosis in operated patients included symptom duration less
than one year and positive Roos test. Patients receiving disability and those with
cervical spine pathology were not considered for surgery. Mean patient age was
39.2 years (range, 14-60 years) with amean follow-up of 104.4months. Eleven
patients (42.3%) engaged in pre-operative physical therapy programs. Seven of
nine patients (26.9%) received adjunctive peri-procedural scalene block with
temporary symptom relief. All patients underwent thoracic outlet decompres-
sion by either first rib resection (18 total: 8 [44%] transaxillary and 10 [66%]
supraclavicular), cervical rib resection (6 [26.1%]), and/or scalenectomy (12
[46.2%]). Of the 22 patients available for follow-up, six patients (27.3%) have
required continued postoperative narcotic analgesics. Sixteen patients (72.7%)
returned to work and reported being at an equivalent or better functional
outcome than their pre-operative status.
Conclusions:Durable long-term functional outcomes can be achieved
predicated on a highly selective approach to the surgical management of
patients with NTOS. A majority of operated patients will not require
adjunctive procedures or chronic narcotic utilization. Patients who undergo
surgery can expect to return to work with little or no functional impairment.
The Effect of Surgical Technique on theMidterm Functional Outcome of
Brachiocephalic Arteriovenous Fistulas: One Incision vs Two Incisions
Costanza M, Stein J, DiRocco J, Ehsani-Chimeh N, Amankwah K, Gahtan V
Objectives: Surgery to create a brachiocephalic arteriovenous fistula
(BCAF) can be performed through one transverse incision distal to the
antecubital fossa or two parallel incisions on the upper arm, proximal to the
antecubital fossa. The prevailing wisdom holds that the choice of one or two
incisions should not affect fistula outcome; however, this assumption has
never been formally evaluated. We compared the functional patency of
BCAF that were created using one vs. two incisions.
Methods:We reviewed the records of all patients who had BCAF surgery
by our division over the last five years. The choice of one or two incisions
depended on surgeon preference. Patients who had BCAF surgery but never
starteddialysiswere excluded. Functional patencywas defined as the timeperiod
during which the fistula was used for hemodialysis. Cumulative functional
patency was the sum of primary, assisted, and secondary functional patency and
the two groups were compared using life table analysis.
Results:We constructed 126 BCAF; 11 patients have yet to start dialysis,
leaving 115 patients as the study population. A total of 50 patients had one
incision and 65 patients had two incisions. At one month follow-up, all fistulas
in both groupswere clinically patent. The fistulawas never used for dialysis in 15
(30%) patients with one incision and in 18 (27%) patients with two incisions. In
both groups, the most common reason for abandonment was non-maturation.
By life table analysis (Fig), fistulas constructed using two incisions had a
significantly longer median cumulative functional patency than fistulas con-
structed using one incision (26 1.1 months vs. 9 1.3 months; P .005).
Conclusions: This non-randomized series suggests that surgical tech-
nique has an effect on fistula function. BCAF constructed using two incisions
demonstrated superior functional patency compared with BCAF constructed
using one incision. The two-incision approach places the arteriovenous anasto-
mosis more proximally on the upper arm compared with the one-incision
approach inwhich the anastomosis is distal to the antecubital fossa.We speculate
that the quality of the artery and vein at this more proximal location could
explain the better durability of the two-incision technique.Fig. Cumulative patency for brachiocephalic AV fistulas.Declotting of Arteriovenous Hemodialysis Acssess: A Comparison of
Percutaneous Mechanical Thrombectomy and Angioplasty versus
Open Thrombectomy
Nahmias JT, Schanzer A, Messina LM, Eslami MH
Objectives: Maintaining patency of arteriovenous hemodialysis access
(AVHA) inmore than 25,000 patients is very costly. This studywas set to compare
the length of stay (LOS), hospital charges, and secondary patency rates of percuta-
neous mechanical thrombectomy (PMTA) versus open thrombectomy (OT).
Methods: A retrospective chart review analysis of a single institution
AVHA thrombectomy cases; 77OT and 36 PMTA cases from 2002 to 2008
were reviewed. We compared the mean and median LOS, mean and median
secondary patency rates, and mean hospital charges. Statistical analyses were
performed using t test and data was significant if P  .05.
Results: OT had a mean LOS of five days, mean hospital charges of
$30,750, and a mean secondary patency of 70 days. PMTA had a mean LOS
of two days, mean hospital charges of $30,006, and a mean secondary
patency of 73 days.
Conclusions: There is a higher mean secondary patency rate and lower
hospital charges for PMTA. Additionally, PMTA had a statistically signifi-
cant lower mean LOS compared with OT (P .0002). Given the significant
less LOS, less charges, and higher patency rates, we concluded that PMTA is
a superior option for AVHA thrombectomy. Cost effectiveness would
require a multi-center prospective randomized trial.
The Effect of Immunosuppression on Lower Extremity Arterial Bypass
Outcomes
Grisafi JL, Dadachanji C, Rahbar R, Muluk SC, Benckart DH
Objectives:Myointimal hyperplasia is a pathologic result of the body’s
natural inflammatory response to blood vessel injury and a leading cause of
early peripheral arterial bypass failure. Since immunosuppressive agents are
known to abate inflammation, we hypothesized superior outcome of lower
extremity bypass in subjects of renal transplantation compared with the
hemodialysis population.
Methods: The vascular surgery registry at a single tertiary care center
was retrospectively reviewed to identify recipients of lower extremity bypass
procedures. All patients with a history of renal transplantation (RT group)
were selected for analysis. The indication of acute arterial occlusion resulted
in exclusion from analysis. Bypass patients with dialysis dependent renal
failure (RF group) were randomly selected to provide a matched control
cohort. Amputation-free survival was the primary endpoint.
Results: See Table for demographics and results. Vascular reconstruction
for chronic peripheral vascular disease (PVD) yielded an amputation-free sur-
vival rate of 80% at one year for theRFgroup comparedwith only 22% in theRT
group (P  .02). There was no statistically significant difference between the
groups in mortality at 30 days and one year, indication for operation, or
comorbid conditions. Indications for operation included severe claudication
(n  1), rest pain (n  1), and tissue loss (n  17). Interestingly, vascular
reconstruction on the extremity ipsilateral to the allograft was required in 67%of
the transplant patients; however, this observationwas not statistically significant.
Conclusions: The results of this study suggest a deleterious effect of
immunosuppression on outcome of lower extremity bypass procedures at
the dosing levels required to prevent allograft rejection. This finding, which
has been scarcely reported, underscores the importance of pre-transplant
PVD screening and timely reconstruction when clinically indicated.
Table. Demographics and results
RT (n  9) RF (n  10) P value
Mean age 54 years 66 years .04
DM 89% 90% 1.0
HTN 100% 100% 1.0
Smoker 0% 44% .08
BMI 27.3 26.4 .78
Prosthetic 11% 40% .3
Amputation-free survival 22% 80% .02
BMI, Body mass index; DM, diabetes mellitus; HTN, hypertension.
Multilevel Versus Isolated Tibial Interventions for Critical Limb Ischemia
Fernandez N, Marone L, Rhee R, Leers S, Makaroun MS, Chaer R
Objectives:Endovascular interventions for critical limb ischemia (CLI)
continue to have variable outcomes. The purpose of this study is to deter-
mine the anatomic predictors of failure for tibial interventions.
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CLI between 2006 and 2009 was performed. Outcomes of isolated tibial
(GI) and multilevel interventions (GII) (femoropopliteal and tibial) were
compared.
Results: Endovascular interventions were utilized to treat 136 limbs in
123 patients for CLI: 82 multilevel (80% tissue loss), 54 isolated tibial (85%
tissue loss). Mean age and baseline comorbidities were comparable. The
mean initial ankle-brachial index (ABI) was significantly lower in GII (0.53
vs. 0.74, P  .001) but was similar post-intervention (0.86 vs. 0.88, P 
NS). Wound healing or improvement was achieved in 69% in GI, and in 87%
in GII (P .05). Time to healing was significantly longer in GI: 11.5 8.8
months vs. 7.7  6.6 months (P  .03). Limb salvage was achieved in 81%
of GI and 95% of GII (P  .05). Mean overall follow up was 8.7  7.3
months. The rate of reintervention was similar (13% vs. 18%, PNS), so was
the rate of late surgical conversion (0% vs. 6%, P  NS). Limb loss resulted
from lack of conduit or initial target vessel for bypass and prohibitive cardiac
co-morbidities. Overall mortality rates were similar among both groups
(mean, 2.5%). Isolated tibial intervention were associated with limb loss at
one year on multivariate analysis, and resulted in a lower rate of limb salvage
at one year compared with multilevel interventions (Fig 1) despite compa-
rable primary patency rates (Fig 2). Predictors of limb loss in patients treated
with isolated tibial intervention included multiple synchronous tibial revas-
cularization (P  .005) and coronary artery disease (CAD) requiring coro-
nary artery bypass graft (CABG) (P  .005).
Conclusions: Adequate rates of limb salvage can be achieved in pa-
tients undergoingmultilevel interventions for CLI, despite low patency rates
at one year. Patients with isolated tibial disease appear to have a higher
incidence of limb loss secondary to poor initial pedal runoff, more extensive
disease, and severe co-morbidities precluding surgical bypass. Other thera-
peutic strategies should be considered in these patients including primary
amputation or pedal bypass when applicable.
Fig 1. Cumulative primary patency (n  134).
Fig 2. Cumulative limb salvage by type of intervention (n 133)Prevalence of Chronic Renal Insufficiency (CRI) and its Impact on
Outcomes of Patients Undergoing Lower Extremity Endovascular
Revascularization
Khan H, Graham AR, Menezes A, et al
Objectives: Chronic renal insufficiency (CRI) is a common co-mor-
bidity in patients undergoing lower extremity revascularization. Tradition-
ally its prevalence has been reported based upon actual serum creatinine (Cr)
value and its presence linked to worse outcomes. We examined the preva-
lence of CRI based upon creatinine clearance and assessed its impact on
outcomes across various groups.
Methods: An Institutional Review Board-approved prospective data-
base of lower extremity revascularizations between 2004 and 2008 was
analyzed. All patients with at least one preoperative Cr value were included
for analysis. Cr clearance was calculated using the Cockcroft-Gault equation.
Renal function was defined as normal, mild, moderate, and severe CRI or
end stage renal disease (ESRD) if Cr clearance was 90, 60-89, 30-59,
15-29, and15 (or documented hemodialysis), respectively. Indications for
intervention were claudication and critical limb ischemia (CLI). Postopera-
tively, patients were followed clinically and by non-invasive vascular studies
at regular intervals. Primary, primary assisted, secondary patency, and limb
salvage rates were calculated using Kaplan-Meier analysis and compared
between the groups.
Results:One thousand five hundred ninety-nine lesions were treated in
667 patients. Only 64 (9.6%) patients had normal (90) Cr clearance.
Demographics are compared in Table I. Female gender, diabetes, and
hypertension were more common in moderate and severe CRI and ESRD.
Mean follow up was 12.7 12.4 months. When lesions in the normal group
were compared with mild, moderate, and severe CRI groups, there was no
difference in primary, primary assisted, and secondary patency in claudicants
at 24 and 36months. Patients with CLI also showed no difference in patency
or limb salvage. Patients with ESRD had significantly worse patency and
limb salvage when compared with non-ESRD patients (Table II).
Conclusions: In our dataset, there was a remarkably high prevalence of
patients with CRI when creatinine clearance was measured. CRI did not
have a negative impact on outcomes in our series except in patients with
ESRD.
Table I. Demographics and characteristics
N (%)
Characteristics Normal (64) Mild (172) Moderate (328) Severe (93) ESRD (63)
Mean age
(years)
60.7  8.7
(37-84)
67.5  8.5
(47-87)
74.6  9.5
(45-94)
78.9  10.5
(48-102)
66.9  11.2
(47-90)
Male 51 (79.7) 122 (70.9) 164 (50.0) 42 (45.2) 42 (66.7)
Diabetes 29 (45.3) 97 (56.4) 204 (62.2) 63 (67.7) 52 (82.5)
Hypertension 48 (75.0) 147 (85.5) 295 (89.9) 88 (94.6) 49 (77.8)
ESRD, End stage renal disease.
Table II. Patency and limb salvage rate at 24 months
Claudicants Critical Limb Ischemia
Primary
Patency
Secondary
Patency
Primary
Patency
Secondary
Patency
Limb
Salvage
Normal 58.37.5 91.04.5 38.78.0 52.28.5 72.17.2
Mild 62.64.7 88.73.1 37.85.0 63.24.9 79.14.0
Moderate 62.63.9 88.82.3 35.03.2 53.33.4 65.53.3
Severe 50.49.7 70.48.9 26.95.9 56.66.4 71.15.8
ESRD 42.27.9 61.96.1 79.53.9
All others (Non
ESRD)
46.11.8 69.31.7 82.81.4
P value ESRD vs
non ESRD
0.12 0.001 0.02
ESRD, End stage renal disease.
Proportion of Critical Ischemia Patients whoRequire anOpen Surgical
Procedure in a Center Favoring Endovascular Treatment
Garguilo NJ III, Veith FJ, Lipsitz EC, Shamul J, O’Connor D, Benros RM,
et al
Objectives: Endovascular interventions have gained widespread famil-
iarity as primary and secondary treatments for critical lower extremity
ischemia (CLI), and many believe there is little need for open bypasses for
